The contribution of animal models to the development of treatments for hematologic recovery following myeloablative therapy: A review

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 6, 1996, Pages 631-646

  Schneidkraut, M J ^a   Hangoc, G ^a   Bender, J G ^a   Huntenburg, C C ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; HEMATOPOIESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030448182     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.631     Document Type: Review

References (226)

1. Ayash, L.J., Elias, A., Wheeler, C., et al. Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer - A feasibility study. J. Clin. Oncol. 12:37, 1994.
2. Bensinger, W.I., Longin, K., Appelbaum, F., et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br. J. Haematol. 87:825, 1994.
3. Coiffier, B., Philip, T., Burnett, A.K., et al. Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies - Lyon, France, June 4-6, 1993. J. Clin. Oncol. 12:226, 1994.
4. Ghalie, R., Reynolds, J., Valentino, L.A., et al. Busulfan-containing pre-transplant regimens for the treatment of solid tumors. Bone Marrow Transplant. 14:437, 1994.
5. Myers, S.E., Mick, R. & Williams, S.F. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: A role for peripheral blood progenitor transplant. Bone Marrow Transplant. 13:449, 1994.
6. O'Shaughnessy, J. A. & Cowan, K.H. Dose-intensive therapy for breast cancer. JAMA 270:2089, 1993.
7. Philip, T., Ladenstein, R., Zucker, J.M., et al. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: The LMCE2 study. Br. J. Cancer 67:119, 1993.
8. Pico, J.L., Ibrahim, A., Castagna, L., et al. Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors. Oncology 50:47, 1993.
9. Shimazaki, C., Oku, N., Uchiyama, H., et al. Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation. Bone Marrow Transplant. 13:271, 1994.
10. Somlo, G., Doroshow, J.H., Forman, S.J., et al. High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. Cancer 73:1678, 1994.
11. Tepler, I., Cannistra, S.A., Frei, E., et al. Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy. J. Clin. Oncol. 11:1583, 1993.
12. Brugger, W., Heimfeld, S., Berenson, R.J., et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N. Engl. J. Med. 333:283, 1995.
13. Zimmerman, T.M., Mick, R., Myers, S., et al. Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapy. Bone Marrow Transplant. 15:923, 1995.
14. Veldhuis, G.J., Willemse, P.H.B., Vangameren, M.M., et al. Recombinant human interleukin-3 to dose-intensify carboplatin and cyclophosphamide chemotherapy in epithelial ovarian cancer: A phase I trial. J. Clin. Oncol. 13:733, 1995.
15. Patrone, F., Ballestrero, A., Ferrando, F., et al. Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer. J. Clin. Oncol. 13:840, 1995.
16. Dhondt, V., Humblet, Y., Guillaume, T., et al. Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: A multicentric placebo-controlled, randomized phase Ib study. Blood 85:2347, 1995.
17. Kennedy, M.J., Armstrong, D.K., Huelskamp, A.M., et al. Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer. J. Clin. Oncol. 13:1136, 1995.
18. Matthay, K.K., Oleary, M.C., Ramsay, N.K., et al. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children's cancer group results. Eur. J. Cancer 31A:572, 1995.
19. Kessinger, A., Bishop, M.R., Anderson, J.R., et al. Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization. J. Hematother. 4:81, 1995.
20. Ayash, L.J., Wheeler, C., Fairclough, D., et al. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. J. Clin. Oncol. 13:2043, 1995.
21. Vahdat, L. & Antman, K. High-dose therapy for breast cancer. Blood Rev. 9:191, 1995.
22. Van Beusechem, V.W., Bart Baumeister, J.A., Bakx, T.A., et al. Gene transfer into nonhuman primate CD34+CD11b-bone marrow progenitor cells capable of repopulating lymphoid and myeloid lineages. Hum. Gen. Ther. 5:295, 1994.
23. Antman, K.H. GM-CSF in marrow transplantation. Eur. J. Cancer 29A:S2, 1993.
24. Bugni, M., Siena, S., Ravagnani, G., et al. High-dose cyclophosphamide in patients with operable breast cancer: Recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia. Haematologica 75 (Suppl. 1):95, 1990.
25. Goldman, J.M., Szydlo, R., Horowitz, M.M., et al. Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 82:2235, 1993.
26. Gore, S.D., Donnenberg, A.D., Zehnbauer, B.A., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery. Leukemia 8:409, 1994.
27. Grzegorzewski, K., Komschlies, K.L., Mon, M., et al. Administration of recombinant human interleukin-7 to mice induces the exportation of myeloid progenitor cells from the bone marrow to peripheral sites. Blood 83:377, 1994.
28. Laporte, J.P., Isnard, F., Lesage, S., et al. Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDs) - A pilot study. Leukemia 7:2030, 1993.
29. Linker, C.A., Ries, C.A., Damon, L.E., et al. Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen. Blood 81:311, 1993.
30. Lowsky, R., Lipton, J., Fyles, G., et al. Secondary malignancies after bone marrow transplantation in adults. J. Clin. Oncol. 12:2187, 1994.
31. Santos, G.W. Autologous bone marrow transplantation (ABMT) in hematological malignancies - Importance of purging and post BMT therapy. Bone Marrow Transplant. 12(Suppl 4):S11, 1993.
32. Sanz, M.A., Delarubia, J., Sanz, G.F., et al. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in 1st complete remission - A report from a single institution. J. Clin. Oncol. 11:1661, 1993.
33. Sasaki, A., Tsukaguchi, M., Hirai, M., et al. Transplantation of allogeneic peripheral blood stem cells after myeloablative treatment of a patient in blastic crisis of chronic myelocytic leukemia. Am. J. Hematol. 47:45, 1994.
34. Sebban, C., Lepage, E., Vernant, J.P., et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: A comparative study. J. Clin. Oncol. 12:2580, 1994.
35. Selvaggi, K.J., Wilson, J.W., Mills, L.E., et al. Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow. Blood 83:1698, 1994.
36. Shaw, P.J., Bergin, M.E., Burgess, M.A., et al. Childhood acute myeloid leukemia: Outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation. J. Clin. Oncol. 12:2138, 1994.
37. Demirer, T., Weaver, C.H., Buckner, C.D., et al. High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy. J. Clin. Oncol. 13:596, 1995.
38. Barge, A.J. A review of the efficacy and tolerability of recombinant hematopoietic growth factors in bone marrow transplantation. Bone Marrow Transplant. 11:1, 1993.
39. Calderwood, S., Romeyer, F., Blanchette, V., et al. Concurrent RhGM-CSF does not offset myelosuppression from intensive chemotherapy: Randomized placebo-controlled study in childhood acute lymphoblastic leukemia. Am. J. Hematol. 47:27, 1994.
40. Dercksen, M.W., Hoekman, K., Huinink, W.W.T., et al. Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours. Br. J. Cancer 68:996, 1993.
41. Dimopoulos, M.A., Hester, J., Huh, Y., et al. Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma. Br. J. Haematol. 87:730, 1994.
42. Frampton, J.E., Lee, C.R. & Faulds, D. Filgrastim - A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 48:731, 1994.
43. Ibrahim, A., Zambon, E., Bourhis, J.H., et al. High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients - A pilot study. Eur. J. Cancer 29A:1398, 1993.
44. Kessinger, A. Is blood or bone marrow better? Stem Cell 11:290, 1993.
45. Kessinger, A. Utilization of peripheral blood stem cells in autotransplantation. Hematol. Oncol. Clin. North Am. 7:535, 1993.
46. Lazarus, H.M. & Rowe, J.M. Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation. Blood Rev. 8:169, 1994.
47. Mansi, J.L., Cunningham, D., Viner, C., et al. Repeat administration of high dose melphalan in relapsed myeloma. Br. J. Cancer 68:983, 1993.
48. Maraninchi, D. The clinical consequences of hematological and non-hematological toxicity following bone marrow transplantation and the possible impact of hematopoietic growth factors. Bone Marrow Transplant. 11:12, 1993.
49. Peters, W.P., Ross, M., Vredenburgh, J., et al. Role of cytokines in autologous bone marrow transplantation. Hematol. Oncol. Clin. North Am. 7:737, 1993.
50. Rampling, R., Steward, W., Paul, J., et al. RhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU. Br. J. Cancer 69:541, 1994.
51. Sica, S., Di Mario, A., Salutari, P., et al. Sequential peripheral blood progenitor cell transplantation after mobilization with salvage chemotherapy and G-CSF in patients with resistant lymphoma. Am. J. Hematol. 46:18, 1994.
52. Tepler, I., Elias, A., Kalish, L., et al. Effect of recombinant human interleukin-3 on haematological recovery from chemotherapy-induced myelosuppression. Br. J. Haematol. 87:678, 1994.
53. Zuckerman, K.S., Case, D.C., Gams, R.A., et al. Chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphomas with an intensive epirubicin-containing regimen. Blood 82:3564, 1993.
54. Reiffers, J., Marit, G. & Boiron, J.-M. Role of high-dose therapy with peripheral blood progenitor cell support in multiple myeloma. J. Hematother. 4:121, 1995.
55. Wilson, W.H., Bates, S.E., Fojo, A., et al. Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. J. Clin. Oncol. 13:1995, 1995.
56. Lu, L., Xiao, M., Clapp, D.W., et al. High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood. J. Exp. Med. 178:2089, 1993.
57. O'Riordan, J.M., Molloy, K., O'Briain, D.S., et al. Localized, late-onset, high-grade lymphoma following bone marrow transplantation - Response to combination chemotherapy. Br. J. Haematol. 86:183, 1994.
58. Suzuki, T., Ochiai, T., Nagata, M., et al. High-dose chemotherapy with autologous bone marrow transplantation in the treatment of advanced gastric. Cancer 72:2537, 1993.
59. Todd, N.W., Peters, W.P., Ost, A.H., et al. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation. Am. Rev. Respir. Dis. 147:1264, 1993.
60. Seiden, M.V., Schlossman, R., Andersen, J., et al. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Leuk. Lymphoma 17:87, 1995.
61. Schmitz, N., Dreger, P., Zander, A.R., et al. Results of a randomized, controlled, multicenter study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. Bone Marrow Transplant. 15:261, 1995.
62. Valteaucouanet, D., Rubie, H., Meresse, V., et al. Phase I-II study of interleukin-2 after high-dose chemotherapy and autologous bone marrow transplantation in poorly responding neuroblastoma. Bone Marrow Transplant. 16:515, 1995.
63. Bacigalupo, A. The clinical benefits of recombinant human granulocyte colony stimulating factor in the treatment of cancer patients. Eur. J. Cancer 30A:S26, 1994.
64. Leibundgut, K., Hirt, A., Ridolfi-Luthy, A., et al. Autotransplants with peripheral blood stem cells and clinical results obtained in children: A review. Eur. J. Pediatr. 152:546, 1993.
65. Yeung, A.W., Pang, Y.K., Tsang, Y.C., et al. Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor - A pilot study by the HongKong Biotherapy Group. Cancer 73:1960, 1994.
66. Klingebiel, T., Handgretinger, R., Herter, M., et al. Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: Nonrandomized comparison between GM-CSF and G-CSF for mobilization. J. Hematother. 4:307, 1995.
67. Brugger, W., Henschler, R., Heimfeld, S., et al. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994.
68. Costello, R.T. Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF) - A review of recent experience. Acta Oncol. 32:403, 1993.
69. Gerhartz, H.H. Reduction of infection rates in cancer patients associated with the use of haematopoietic growth factors. Eur. J. Cancer 29A(Suppl. 3):S14, 1993.
70. Gianellaborradori, A. Present and future clinical relevance of interleukin 3. Stem Cell 12:241, 1994.
71. Gianni, A.M., Bregni, M., Siena, S., et al. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J. Clin. Oncol. 8:768, 1990.
72. Laughlin, M.J., Kirkpatrick, G., Sabiston, N., et al. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors - G-CSF, GM-CSF, IL-1, IL-2, M-CSF. Ann. Hematol. 67:267, 1993.
73. Nemunaitis, J., Rabinowe, S.N., Singer, J.W., et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N. Engl. J. Med. 324:1773, 1991.
74. Steward, W.P. Granulocyte and granulocyte-macrophage colony-stimulating factors. Lancet 342:153, 1993.
75. Klumpp, T.R., Mangan, K.F., Goldberg, S.L., et al. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem cell transplantation: A prospective, randomized trial. J. Clin. Oncol. 13:1323, 1995.
76. Bishop, M.R., Anderson, J.R., Jackson, J.D., et al. High-dose therapy and peripheral blood progenitor cell transplantation - Effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 83:610, 1994.
77. Craig, J.I.O., Anthony, R.S., Stewart, A., et al. Peripheral blood stem cell mobilization using high-dose cyclophosphamide and G-CSF in pretreated patients with lymphoma. Br. J. Haematol. 85:210, 1993.
78. Hohaus, S., Goldschmidt, H., Ehrhardt, R., et al. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp. Hematol. 21:508, 1993.
79. Mangan, K., Mullaney, M., Klumpp, T., et al. Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor - A phase I-II study. Stem Cell 11:445, 1993.
80. Olivieri, A., Offidani, M., Ciniero, L., et al. Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: Proposal for a mathematical model. Bone Marrow Transplant. 14:273, 1994.
81. Sato, N., Sawada, K., Takahashi, T.A., et al. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp. Hematol. 22:973, 1994.
82. Tjonnfjord, G.E., Steen, R., Evensen, S.A., et al. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony stimulating factor. Blood 84:2795, 1994.
83. Vose, J.M. & Armitage, J.O. Clinical applications of hematopoietic growth factors. J. Clin. Oncol. 13:1023, 1995.
84. McNiece, I.K. & Briddell, R.A. Stem cell factor. J. Leukocyte Biol. 58:14, 1995.
85. Chen, B.P., Fraser, C., Reading, C., et al. Cytokine-mobilized peripheral blood CD34(+)Thy-1(+)Lin(-) human hematopoietic stem cells as target cells for transplantation-based gene therapy. Leukemia 9:S17, 1995.
86. Molineux, G., Migdalska, A., Szmitkowski, M., et al. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961, 1991.
87. Molineux, G., Pojda, Z., Hampson, I.N., et al. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 76:2153, 1990.
88. Morstyn, G., Glaspy, J., Shpall, E.J., et al. Clinical applications of Filgrastim and stem cell factor in vivo and in vitro. J. Hematother. 3:353, 1994.
89. Sheridan, W.P. Transplantation of mobilized peripheral blood stem cells: Role of Filgrastim. J. Hematother. 3:349, 1994.
90. Van, X-Q., Briddell, R., Hartley, C., et al. Mobilization of long-term hematopoietic reconstituting cells in mice by the combination of stem cell factor plus granulocyte colony-stimulating factor. Blood 84:795, 1994.
91. McNiece, I.K., Briddell, R.A., Hartley, C.A., et al. Stem cell factor enhances in vivo effects of granulocyte colony stimulating factor for stimulating mobilization of peripheral blood progenitor cells. Stem Cell 11(Suppl. 2):36, 1993.
92. Gasparetto, C., Smith, C., Gillio, A., et al. Enrichment of peripheral blood stem cells in a primate model following administration of a single dose of rh-IL-1 beta. Bone Marrow Transplant. 14:717, 1994.
93. O'Reilly, R.J., Gillio, A. & Gasparetto, C. Effects of hematopoietic growth factors following myeloablation in a primate model. Int. J. Cell. Cloning 8(Suppl 1):262, 1990.
94. Molineux, G., Pojda, Z. & Dexter, T.M. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 75:563, 1990.
95. McNiece, I.K., Briddell, R.A., Van, X-Q., et al. The role of stem cell factor in mobilization of peripheral blood progenitor cells. Leuk. Lymphoma 15:405, 1994.
96. Scheding, S., Brugger, W., Mertelsmann, R., et al. Peripheral blood stem cells: In vivo biology and therapeutic potential. Stem Cell 12:203, 1994.
97. Briddell, R.A., Hartley, C.A., Smith, K.A., et al. Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993.
98. McNiece, I.K., Briddell, R.A., Hartley, C.A., et al. The role of stem cell factor in mobilization of peripheral blood progenitor cells - Synergy with G-CSF. Stem Cell 11:83, 1993.
99. Khwaja, A., Mills, W., Leveridge, K., et al. Efficacy of delayed granulocyte colony-stimulating factor after autologous BMT. Bone Marrow Transplant. 11:479, 1993.
100. Mertelsmann, R. Hematopoietic cytokines - From biology and pathophysiology to clinical application. Leukemia 7:S168, 1993.
101. Peters, W.P. Use of cytokines during prolonged neutropenia associated with autologous bone marrow transplantation. Rev. Infect. Dis. 13:993, 1991.
102. MacVittie, T.J., Farese, A.M., Patchen, M.L., et al. Therapeutic efficacy of recombinant interleukin-6 (IL-6) alone and combined with recombinant human IL-3 in a nonhuman primate model of high-dose, sublethal radiation-induced marrow aplasia. Blood 84:2515, 1994.
103. Farese, A.M., Williams, D.E., Seiler, F.R., et al. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood 82:3012, 1993.
104. van Bekkum, D.W., Wielenga, J.J., van Gils, F., et al. Factors influencing reconstitution by bone marrow transplantation. Prog. Clin. Biol. Res. 352:479, 1990.
105. Tamura, M., Matsumoto, M., Yoshino, T., et al. Effects of recombinant human granulocyte colony-stimulating factor on the mice receiving bone marrow transplantation following lethal irradiation: Acceleration of recovery of the peripheral blood neutrophils and potentiation of anti-Pseudomonas resistance. Exp. Hematol. 19:18, 1991.
106. Tamura, M., Yoshino, T., Hattori, K., et al. Acceleration of the hematopoietic reconstitution in mice undergoing bone marrow transplantation by recombinant human granulocyte colony-stimulating factor. Transplantation 51:1166, 1991.
107. Wheeler, J.G., Huffine, M.E., Childress, S., et al. Comparison of colony-stimulation factors on in vitro rat and human neutrophil function. Biol. Neonate 66:214, 1994.
108. McCullough, J. Collection and use of stem cells: Role of transfusion centers in bone marrow transplantation. Vox Sang. 67 (Suppl 3):35, 1994.
109. Fernandez, F.A.G., Martinez, A.V., Llorente, L., et al. Detecting the minimal residual disease contaminated in peripheral blood stem cell transplantation in B-cell lymphoma. Am. J. Hematol. 44:73, 1993.
110. Ross, A.A. Detection and viability of tumor cells in peripheral blood stem cell and bone marrow collections from breast cancer patients - response. Blood 83:2007, 1994.
111. Ross, A.A., Cooper, B.W., Lazarus, H.M., et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993.
112. Seriu, T., Yokota, S., Nakao, M., et al. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Leukemia 9:615, 1995.
113. Takatsuki, H., Umemura, T., Sadamura, S., et al. Detection of minimal residual disease by reverse transcriptase polymerase chain reaction for the PML/RAR alpha fusion mRNA: A study in patients with acute promyelocytic leukemia following peripheral stem cell transplantation. Leukemia 9:889, 1995.
114. Levy, J.G., Dowding, C., Mitchell, D., et al. Selective elimination of malignant stem cells using photosensitizers followed by light treatment. Stem Cells 13:336, 1995.
115. Almici, C., Manoni, L., Carlostella, C., et al. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow. Bone Marrow Transplant. 16:95, 1995.
116. Gale, R.P., Reiffers, J. & Juttner, C.A. What's new in blood progenitor cell autotransplants? Bone Marrow Transplant. 14:343, 1994.
117. Rosenfeld, C.S., Gremba, C., Shadduck, R.K., et al. Engraftment with peripheral blood stem cells using non-controlled-rate cryopreservation - Comparison with autologous bone marrow transplantation. Exp. Hematol. 22:290, 1994.
118. Brugger, W., Bross, K.J., Glatt, M., et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
119. Moss, T.J. & Ross, A.A. The risk of tumor cell contamination in peripheral blood stem cell collections. J. Hematother. 1:225, 1992.
120. Sharp, J.G., Mann, S.L., Murphy, B., et al. Culture methods for the detection of minimal tumor contamination of hematopoietic harvests: A review. J. Hematother. 4:141, 1995.
121. Shpall, E.J., Jones, R.B., Bearman, S.I., et al. Transplantation of enriched cd34-positive autologous marrow into breast cancer patients following high-dose chemotherapy - Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12:28, 1994.
122. Shpall, E.J., Jones, R.B., Bearman, S.I., et al. Transplantation of CD34+ hematopoietic progenitor cells. J. Hematother. 3:145, 1994.
123. Shpall, E.J., Jones, R.B., Bearman, S.I., et al. Positive selection of CD34+ hematopoietic progenitor cells for transplantation. Stem Cell 11:48, 1993.
124. Dreger, P., Viehmann, K., Steinmann, J., et al. CD48 monoclonal antibody K31 for bone marrow transplantation - T-depleting capacity and influence on hematopoietic progenitors. Bone Marrow Transplant. 12:S13, 1993.
125. Fruehauf, S., Haas, R., Zeller, W.J., et al. CD34 selection for purging in multiple myeloma and analysis of CD34(+) B cell precursors. Stem Cell 12:95, 1994.
126. Smith, L.G., Weissman, I.L. & Heimfeld, S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc. Natl. Acad. Sci. USA 88:2788, 1991.
127. Uchida, N., Aguila, H.L., Fleming, W.H., et al. Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1(lo) Lin(-) Sca1(+) hematopoietic stem cells. Blood 83:3758, 1994.
128. Krause, D.S., Ito, T., Fackler, M.J., et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84:691, 1994.
129. Berenson, R.J., Andrews, R.G., Bensinger, W.I., et al. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 81:951, 1988.
130. Kritz, A., Crown, J.P., Motzer, R.J., et al. Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. Cancer 71:2515, 1993.
131. Gisselbrecht, C., Prentice, H.G., Bacigalupo, A., et al. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet 343:696, 1994.
132. Kotasek, D., Sage, R.E., Dale, B.M., et al. Dose intensive therapy with autologous blood stem cell transplantation in breast cancer. Aust. NZ J. Med. 24:288, 1994.
133. Dercksen, M.W., Rodenhuis, S., Dirkson, M.K.A., et al. Subsets of CD34(+) cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J. Clin. Oncol. 13:1922, 1995.
134. Huestis, D.W. & Glasser, L. The neutrophil in transfusion medicine. Transfusion 34:630, 1994.
135. Atkinson, K., Downs, K. & Hawkins, T. Hematopoietic stem cell transplantation in Australia in 1993. J. Hematother. 4:45, 1995.
136. Robinson, L.A., Reed, E.G., Galbraith, T.A., et al. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients. J. Thorac. Cardiovasc. Surg. 109:1182, 1995.
137. Grigg, A. & Clouston, D. Disseminated fungal infection and early onset microangiopathy after allogeneic bone marrow transplantation. Bone Marrow Transplant. 15:795, 1995.
138. Huang, S. & Terstappen, L.W.M.M. Lymphoid and myeloid differentiation of single human CD34(+), HLA-DR(+), CD38(-) hematopoietic stem cells: Blood 83:1515, 1994.
139. Koller, M.R., Bender, J.G., Papoutsakis, E.T., et al. Effects of synergistic cytokine combinations, low oxygen, and irradiated stroma on the expansion of human cord blood progenitors. Blood 80:406, 1992.
140. McCrady, C.W., Li, F., Pettit, G.R., et al. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor interleukin-3 fusion protein (PIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1. Exp. Hematol. 21:893, 1993.
141. Smith, S.L., Bender, J.G., Maples, P.B., et al. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow. Exp. Hematol. 21:870, 1993.
142. Zandstra, P.W., Eaves, C.J. & Piret, J.M. Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells. Biotechnology 12:909, 1994.
143. Lill, M.C., Lynch, M., Fraser, J.K., et al. Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system. Stem Cell 12:626, 1994.
144. Warren, M.K., Rose, W.L., Beall, D., et al. CD34(+) cell expansion and expression of lineage markers during liquid culture of human progenitor cells. Stem Cell 13:167, 1995.
145. Fabian, I., Bleiberg, I., Riklis, I., et al. Enhanced reconstitution of hematopoietic organs in irradiated mice, following their transplantation with bone marrow cells pre-treated with recombinant interleukin 3. Exp. Hematol. 15:1140, 1987.
146. Muench, M.O., Firpo, M.T. & Moore, M.A.S. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without loss of stem cell lineage and proliferative potential. Blood 81:3463, 1993.
147. Muench, M.O., Roncarolo, M.G., Namikawa, R., et al. Progress in the ex vivo expansion of hematopoietic progenitors. Leuk. Lymphoma. 16:1, 1994.
148. Slavin, S., Mumcuoglu, M., Landesberg-Weisz, A., et al. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effect of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z). Bone Marrow Transplant. 4:459, 1989.
149. Tavassoli, M., Konno, M., Shiota, Y., et al. Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood 77:1599, 1991.
150. Serrano, F., Varas, F., Bernad, A., et al. Accelerated and long-term hematopoietic engraftment in mice transplanted with ex vivo expanded bone marrow. Bone Marrow Transplant. 14:855, 1994.
151. Gordon, M.Y. Human hematopoietic stem cell assays. Blood Rev. 7:190, 1993.
152. Peschle, C., Testa, U., Valtieri, M., et al. Stringently purified human hematopoietic progenitors/stem cells - Analysis of cellular/molecular mechanisms underlying early hematopoiesis. Stem Cell 11:356, 1993.
153. Lemoli, R.M. & Gulati, S.C. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin-3 on hematopoietic progenitors in human long-term bone marrow cultures. Stem Cell 11:435, 1993.
154. Verfaillie, C.M. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 82:2045, 1993.
155. Sutherland, H.J., Hogge, D.E. & Eaves, C.J. Growth factor regulation of the maintenance and differentiation of human long-term culture-initiating cells (LTC-IC). Leukemia 7:S122, 1993.
156. Lansdorp, P.M. & Dragowska, W. Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruitment of quiescent progenitors. Exp. Hematol. 21:1321, 1993.
157. Lemoli, R.M., Fogli, M., Fortuna, A., et al. Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor beta 3 (TGF-beta 3) on human primitive hematopoietic progenitor cells. Haematologica 80:5, 1995.
158. Wognum, A.W., Westerman, Y., Visser, T.P., et al. Distribution of receptors for granulocyte-macrophage colony-stimulating factor on immature CD34+ bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets. Blood 84:764, 1994.
159. Srour, E.F., Brandt, J.E., Briddell, R.A., et al. Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis [Review]. Blood Cells 17:287, 1991.
160. Gabbianelli, M., Pelosi, E., Montesoro, E., et al. Multi-level effects of flt3 ligand on human hematopoiesis: Expansion of putative stem cells and proliferation of granulomonocytic progenitors monocytic precursors. Blood 86:1661, 1995.
161. Jacobsen, S.E.W., Jacobsen, F.W., Fahlman, C., et al. TNF-alpha, the great imitator: Role of p55 and p75 TNF receptors in hematopoiesis. Stem Cell 12:111, 1994.
162. Kobayashi, M., Laver, J.H., Kato, T., et al. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 86:2494, 1995.
163. Moore, M.A., Muench, M.O., Warren, D.J., et al. Cytokine networks involved in the regulation of hemopoietic stem cell proliferation and differentiation. Ciba Found. Symp. 148:43, 1990.
164. Siena, S., Bregni, M., Bonsi, L., et al. Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophamide and cytokine(s). Stem Cell 11:72, 1993.
165. Hoffman, R., Tong, J., Brandt, J., et al. The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Stem Cell 11:76, 1993.
166. Civin, C.I. & Gore, S.D. Antigenic analysis of hematopoiesis: A review. J. Hematother. 2:137, 1993.
167. Aglietta, M., Sanavio, F., Stacchini, A., et al. Interleukin-3 in vivo - Kinetic of response of target cells. Blood 82:2054, 1993.
168. Morstyn, G., Brown, S., Gordon, M., et al. Stem cell factor is a potent synergistic factor in hematopoiesis. Oncology 51:205, 1994.
169. Vadhan-Raj, S. PIXY321 (GM-CSF/IL-3 fusion protein) - Biology and early clinical development. Stem Cell 12:253, 1994.
170. Brugger, W., Henschler, R., Heimfeld, S., et al. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994.
171. Weisdorf, D., Katsanis, E., Verfaillie, C.M., et al. Interleukin-1 alpha administered after autologous transplantation: A phase I/II clinical trial. Blood 84:2044, 1994.
172. Zanjani, E.D., Pallavicini, M.G., Harrison, M.R., et al. Successful stable xenograft of human fetal hemopoietic cells in preimmune fetal sheep. Trans. Assoc. Am. Physicians 104:181, 1991.
173. Rice, H.E., Flake, A.W., Hedrick, M.H., et al. Effect of xenogeneic chimerism in a human/sheep model on natural antibody. J. Surg. Res. 54:355, 1993.
174. Srour, E.F., Zanjani, E.D., Cornetta, K., et al. Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood 82:3333, 1993.
175. Zanjani, E.D., Flake, A.W., Rice, H., et al. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep [see Comments]. J. Clin. Invest. 93:1051, 1994.
176. Flake, A.W., Hendrick, M.H., Rice, H.E., et al. Enhancement of human hematopoiesis by mast cell growth factor in human-sheep chimeras created by the in utero transplantation of human fetal hematopoietic cells. Exp. Hematol. 23:252, 1995.
177. Zanjani, E.D., Pallavacini, M.G., Ascensao, J.L., et al. Human-ovine xenogenic transplantation of stem cells in utero. Bone Marrow Transplant. 9(Suppl 1):86, 1992.
178. Flake, A.W. & Zanjani, E.D. In utero transplantation of hematopoietic stem cells [Review]. Crit. Rev. Oncol. Hematol. 15:35, 1993.
179. Srour, E.F., Zanjani, E.D., Brandt, J.E., et al. Sustained human hematopoiesis in sheep transplanted in utero during early gestation with fractionated adult human bone marrow cells. Blood 79:1404, 1992.
180. Zanjani, E.D., Ascensao, J.L., Flake, A.W., et al. The fetus as an optimal donor and recipient of hematopoietic stem cells. Bone Marrow Transplant. 10(Suppl 1):107, 1992.
181. Zanjani, E.D., Pallavicini, M.G., Ascensao, J.L., et al. Engraftgment and long-term expression of human fetal hematopoietic stem cells in sheep following transplantation in utero. J. Clin. Invest. 89:1178, 1992.
182. Zanjani, E.D., Ascensao, J.L., Harrison, M.R., et al. Ex vivo incubation with growth factors enhances the engraftment of fetal hematopoietic cells transplanted in sheep fetuses. Blood 79:3045, 1992.
183. Gallohendrikx, E., Copps, J., Percy, D., et al. Enhancement of pancreatic tumor metastasis in transgenic immunodeficient mice. Oncogene 9:2983, 1994.
184. Murphy, W.J., Reynolds, C.W., Tiberghien, P., et al. Natural killer cells and bone marrow transplantation. J. Natl. Cancer Inst. 85:1475, 1993.
185. Converse, P.J., Haines, V.L., Wondimu, A., et al. Infection of SCID mice with Mycobacterium leprae and control with antigen-activated "Immune" human peripheral blood mononuclear cells. Infect. Immun. 63:1047, 1995.
186. Hesselton, R.M., Koup, R.A., Cromwell, M.A., et al. Human peripheral blood xenografts in the SCID mouse - Characterization of immunologic reconstitution. J. Infect. Dis. 168:630, 1993.
187. Kollmann, T.R., Kim, A., Zhuang, X.J., et al. Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines. Proc. Natl. Acad. Sci. USA 91:8032, 1994.
188. Lapidot, T., Pflumio, F., Doedens, M., et al. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137, 1992.
189. McCune, J.M. The SCID-hu mouse: A small animal model for the analysis of human hematolymphoid differentiation and function. Bone Marrow Transplant. 9(Suppl 1):74, 1992.
190. Peault, B., Weissman, I.L., Buckle, A.M., et al. Thy-1-expressing CD34+ human cells express multiple hematopoietic potentialities in vitro and in SCID-hu mice. Nouv. Rev. Fr. Hematol. 35:91, 1993.
191. Prakapas, Z., Denoyelle, M., Thiery, J.P., et al. Analysis of early reconstitution events in the scid mouse thymus following rat bone marrow cell transplantation. Immunol. Lett. 37:63, 1993.
192. Shiroki, R., Poindexter, N.J., Woodle, E.S., et al. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice - A model for human islet allograft rejection. Transplantation 57:1555, 1994.
193. Tary-Lehmann, M., Lehmann, P.V., Schols, D., et al. Anti-SCID mouse reactivity shapes the human CD4(+) T cell repertoire in hu-P8L-SCID chimeras. J. Exp. Med. 180:1817, 1994.
194. Larochelle, A., Vormoor, J., Lapidot, T., et al. Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: Implications for evaluating human gene therapy protocols. Hum. Mol. Genet. 4:163, 1995.
195. Baum, C.M., Weissman, I.L., Tsukamoto, A.S., et al. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 89:2804, 1992.
196. Chen, B.P., Galy, A., Kyoizumi, S., et al. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. Blood 84:2497, 1994.
197. Dick, J.E., Lapidot, T. & Pflumio, F. Transplantation of normal and leukemic human bone marrow into immune-deficient mice: Development of animal models for human hematopoiesis. Immunol. Rev. 124:25, 1991.
198. Galy, A.H.M., Webb, S., Cen, D.H., et al. Generation of T cells from cytokine-mobilized peripheral blood and adult bone marrow CD34+ cells. Blood 84:104, 1994.
199. Kaneshima, H., Namikawa, R. & McCune, J.M. Human hematolymphoid cells in SCID mice. Curr. Opin. Immunol. 6:327, 1994.
200. Kyoizumi, S., Baum, C.M., Kaneshima, H., et al. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 79:1704, 1992.
201. Leigh, B.R., Webb, S., Hancock, S.L., et al. Stem cell factor enhances the survival of irradiated human bone marrow maintained in SCID mice. Stem Cell 12:430, 1994.
202. Namikawa, R., Ueda, R. & Kyoizumi, S. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. Blood 82:2526, 1993.
203. Pflumio, F., Lapidot, T., Murdoch, B., et al. Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int. Immunol. 5:1509, 1993.
204. Namikawa, R., Weilbaecher, K.N., Kaneshima, H., et al. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172:1055, 1990.
205. Peault, B., Weissman, I. & Baum, C. Analysis of candidate human blood stem cells in humanized immune-deficiency SCID mice. Leukemia 7:S98, 1993.
206. Vormoor, J., Lapidot, T., Pflumio, F., et al. SCID mice as an in vivo model of human cord blood hematopoiesis. Blood Cells 20:316, 1994.
207. Harris, D.T. In vitro and in vivo assessment of the graft-versus-leukemia activity of cord blood. Bone Marrow Transplant. 15:17, 1995.
208. Kamel-Reid, S. & Dick, J.E. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242:1706, 1988.
209. Vormoor, J., Lapidot, T., Pflumio, F., et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 83:2489, 1994.
210. Kyoizumi, S., Murray, L.J. & Namikawa, R. Preclinical analysis of cytokine therapy in the SCID-hu mouse. Blood 81:1479, 1993.
211. McCune, J.M., Namikawa, R., Kaneshima, H., et al. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632, 1988.
212. Peault, B. Analysis of human blood cell development in the SCID-hu mouse, an in-vivo replica of the human fetal hematopoietic system. C. R. Acad. Sci.[III] 316:906, 1993.
213. Peault, B., Weissman, I.L., Baum, C., et al. Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells. J. Exp. Med. 174:1283, 1991.
214. Greiner, D.L., Shultz, L.D., Yates, J., et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am. J. Pathol. 146:888, 1995.
215. Galy, A.H.M., Cen, D.Z., Travis, M., et al. Delineation of T-progenitor cell activity within the CD34(+) compartment of adult bone marrow. Blood 85:2770, 1995.
216. Fraser, C.C., Kaneshima, H., Hansteen, G., et al. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft. Blood 86:1680, 1995.
217. Moore, T.A. & Zlotnik, A. T-cell lineage commitment and cytokine responses of thymic progenitors. Blood 86:1850, 1995.
218. Carballido, J.M., Schols, D., Namikawa, R., et al. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice - Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist. J. Immunol. 155:4162, 1995.
219. Nolta, J.A., Hanley, M.B. & Kohn, D.B. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors. Blood 83:3041, 1994.
220. Liu, J.M., Kim, S. & Walsh, C.E. Retroviral-mediated transduction of the Fanconi anemia C complementing (FACC) gene in two murine transplantation models. Blood Cells Molecules Dis. 21:56, 1995.
221. Richardson, C. & Bank, A. Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene. Blood 86:2579, 1995.
222. Schiffmann, R., Medin, J.A., Ward, J.M., et al. Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: Successful engraftment and long-term expression of the transgene. Blood 86:1218, 1995.
223. Van Beusechem, V.W., Kukler, A., Heidt, P.J., et al. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc. Natl. Acad. Sci. USA 89:7640, 1992.
224. Kaptein, L.C., Einerhand, M.P., Braakman, E., et al. Bone marrow gene therapy for adenosine deaminase deficiency. Immunodeficiency 4:335, 1993.
225. Van Beusechem, V.W., Bakx, T.A., Kaptein, L.C., et al. Retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells: The effect of viral titers on transduction efficiency. Human Gene Then 4:239, 1993.
226. Akkina, R.K., Rosenblatt, J.D., Campbell, A.G., et al. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 84:1393, 1994.